What is the appropriate management for a patient with a hemoglobin of 6.9 g/dL and iron deficiency?

Management of Hemoglobin 6.9 g/dL with Iron Deficiency

Start oral iron therapy immediately with ferrous sulfate 200 mg (65 mg elemental iron) once daily on an empty stomach, and assess for symptoms of cardiovascular compromise to determine if blood transfusion is needed. 1

Immediate Assessment

First, evaluate for symptomatic anemia requiring urgent intervention:

• Chest pain, shortness of breath at rest, or dizziness with standing
• Tachycardia, diaphoresis, or poor capillary refill
• Signs of circulatory compromise or hemodynamic instability

Blood transfusion is rarely required for iron deficiency anemia, even at this hemoglobin level, because most patients with slowly developing anemia adapt physiologically 1. However, if the patient has severe symptoms or circulatory compromise, transfuse packed red cells to a target hemoglobin of 70-90 g/dL (80-100 g/dL if unstable coronary artery disease is present) 1.

Critical Point on Transfusion

A unit of packed red cells contains only about 200 mg of elemental iron—this will not replenish iron stores in severe iron deficiency anemia 1. Therefore, even if you transfuse, you must still provide adequate iron replacement therapy afterward.

Iron Replacement Strategy

First-Line: Oral Iron Therapy

Prescribe ferrous sulfate 200 mg once daily (provides 65 mg elemental iron), taken on an empty stomach 1. This represents the optimal balance between efficacy and tolerability based on recent evidence.

Key prescribing details:

• Taking iron with 500 mg vitamin C improves absorption 2
• If not tolerated on empty stomach, can take with meals (preferably with meat protein) 2
• Alternative: ferrous fumarate 210 mg or ferrous gluconate 300 mg once daily 1

If gastrointestinal side effects occur (nausea, abdominal pain, constipation):

• Switch to alternate-day dosing (same dose every other day)—this produces similar hemoglobin increments with significantly lower nausea rates 1
• Consider ferric maltol 30 mg twice daily (better tolerated but more expensive) 1
• Do not switch between different ferrous salts—this is not supported by evidence 1

When to Use Intravenous Iron Instead

Consider IV iron as first-line therapy in these situations 2, 3:

• Severe iron deficiency requiring rapid correction
• Conditions causing malabsorption (celiac disease, inflammatory bowel disease, post-gastric surgery)
• Chronic kidney disease or heart failure
• Anticipated poor response to oral iron
• Ongoing blood loss exceeding intestinal iron absorption capacity

Available IV iron formulations (from 1):

• Ferric carboxymaltose: 1000 mg single dose, 15-minute infusion, no test dose required
• Ferric derisomaltose: up to 20 mg/kg single dose, 15-30 minute infusion
• Iron sucrose: 200 mg per injection, requires test dose

Monitoring Protocol

Week 2: Check hemoglobin 1

• If hemoglobin rise <10 g/L: This predicts treatment failure with 90% sensitivity 1
• Causes of inadequate response: non-compliance, malabsorption, ongoing bleeding, systemic disease, bone marrow pathology, concurrent B12/folate deficiency
• Action: Switch to IV iron or investigate for other causes

Week 4 and monthly thereafter: Monitor hemoglobin until normalized 1

After hemoglobin normalizes: Continue oral iron for 2-3 additional months to replenish iron stores 1

Long-term follow-up: Check complete blood count every 3 months for 12 months, then every 6 months for 2-3 years to detect recurrent anemia 1

Investigation of Underlying Cause

Do not defer iron replacement while awaiting investigations unless colonoscopy is imminent 1. However, identifying the source of iron deficiency is essential:

• Premenopausal women: Assess menstrual blood loss and dietary iron intake 2
• Men and postmenopausal women: Require bidirectional endoscopy (upper endoscopy and colonoscopy) to evaluate for gastrointestinal blood loss 2, 1
• All patients: Screen for celiac disease, assess for Helicobacter pylori infection 2

If bidirectional endoscopy is negative and anemia persists or recurs, proceed to capsule endoscopy to evaluate the small bowel 1.

Common Pitfalls

1. Transfusing instead of treating with iron: At hemoglobin 6.9 g/dL without severe symptoms, iron therapy (especially IV) will produce clinically meaningful response within one week 4

2. Using inadequate oral iron doses: Many providers prescribe 2-3 times daily dosing, which increases side effects without improving efficacy 1

3. Stopping iron too early: Must continue for 2-3 months after hemoglobin normalizes to replenish stores 1

4. Not monitoring early response: The 2-week hemoglobin check is critical to identify treatment failures early 1